Institutional investors purchased a net $1.3 million shares of NEO during the quarter ended June 2019, and now own 89.80% of the total float, a percentage that is typical for companies in the Medical/Nursing Services industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
ASSENAGON ASSET MANAGEMENT SA (G... Bought 3.6 Million shares of Neogenomics Inc
FIRST LIGHT ASSET MANAGEMENT LLC Bought 1.9 Million shares of Neogenomics Inc
BARCLAYS BANK PLC (PRIVATE BANKI... Bought 1.5 Million shares of Neogenomics Inc